Vetsys Pharmaceutical
Vetsys Pharmaceutical
The global injectable liquids market is undergoing a transformative shift driven by the demand for rapid pharmacological bioavailability and the rise of precision veterinary medicine. As an OEM/ODM leader, we recognize that the future of this sector lies in the integration of AI-driven synthesis, cold-chain logistics optimization, and rigorous compliance with international Pharmacopoeia standards.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. leverages the robust manufacturing ecosystem of China. Unlike competitors, we have integrated the entire supply chain—from raw API procurement to sterile vial sterilization and final packaging. This vertical integration allows us to:
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Established 2005) stands as a cornerstone in the animal pharmaceutical industry. With a registered capital of 30 million RMB, we don't just manufacture; we engineer health solutions.
Our facility encompasses specialized workshops for a wide range of formats: powders, premixes, injectables, oral solutions, and herbal extracts. Our compliance with Good Manufacturing Practices (GMP) is not just a regulatory checklist—it is the bedrock of our operational philosophy, ensuring every batch meets the highest global quality standards.
Vetsys distinguishes itself through an independent research institute featuring five specialized laboratories and world-class scientists. We prioritize Information Gain—we don't just copy standard formulations; we innovate to enhance drug stability, reduce injection site irritation, and improve absorption kinetics.
We provide comprehensive end-to-end support, including formulation development, regulatory documentation assistance, and GMP-certified manufacturing, ensuring your products enter the market faster and with higher safety profiles.
We are well-versed in global veterinary drug regulations. Our team actively participates in international audits and aligns our production protocols with WHO-GMP and specific target market pharmaceutical standards.
Yes. Our extraction facilities for traditional herbal medicine (like Astragalus and Salvia) combined with our synthetic pharmaceutical synthesis capabilities allow us to create unique, hybrid medicinal products.
